Tuesday, August 22, 2023

Acupuncture Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market overview

Market Research Future (MRFR) has launched a new release on the global acupuncture market. The report provides comprehensive coverage of the market’s growth prospects over the forecast period till 2032, based on a detailed analysis of the market’s key growth drivers and markers derived from the market’s historical growth trajectory. The global acupuncture market size is projected to reach at USD 157.73 billion by 2030 at a CAGR 17.10% during forecast period 2023-2032, according to the report.

Acupuncture is a part of traditional Chinese medicine (TCM) and consists of lightly piercing a patient’s body with small needles in order to influence and manipulate the flow of the patient’s life force, or “qi”, an essential concept in TCM. The needles are placed at strategic spots chosen due to their connection with the overall flow of qi within the patient’s body. The technique of acupuncture emerged in ancient China, but has gained significant popularity in modern-day U.S. The growth of the New Age movement has considerably helped spread the acupuncture market in Western regions, where it is now considered a pseudoscience but an established part of the wide spectrum of alternative medicine.

Acupuncture has been shown to have some effect in pain treatment; however, evidence demonstrating its efficacy in treating other medical conditions and even serious pain resulting from potentially terminal conditions is lacking. Acupuncture is now also being used in gynecological conditions related to menopause or PMS. Most of the clinical effects of acupuncture are thought to originate from the placebo effect and the overall calming effect of the setting, which may help in pain relief on its own. Nevertheless, the growing demand for alternative medicine in the U.S. has emerged as a significant driver for the global acupuncture market. On the other hand, the lack of insurance coverage for acupuncture and relatively expensive per-visit fees could hamper the market’s growth prospects in Western economies over the forecast period.

Competitive Analysis:

Global Acupuncture Market Players are Wuxi Jiajian Medical Instruments Co. Ltd., 3B Scientific GmbH, Zepter International, MKW Laser System GmbH, Qingdao Great Fortune Co. Ltd., AcuMedic Ltd., Asia-med GmbH, Cymedics GmbH & Co. KG, SEIRIN Corporation, and Schwa-medico GmbH.

Segmentation:

The global acupuncture market is segmented on the basis of component type, application, end user, and region.

By component, the global acupuncture market is segmented into services and products.

By application, the global acupuncture market is segmented into pain syndrome illnesses, gynecological disorders, psychological disorders, and others.

By end use, the acupuncture market is segmented into wellness centers, hospitals and specialty clinics, and research and academic institutes.

Regional Analysis:

By region, the global acupuncture market insights is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas segment is sub-segmented into the U.S., Canada, and South America. Europe is further categorized into Western Europe, containing Germany, France, the UK, Spain, Italy, and the rest of Western Europe, and Eastern Europe. Asia Pacific is further segmented into Japan, China, India, Australia, South Korea, and the rest of Asia Pacific.

Asia Pacific is likely to retain a dominant share in the global acupuncture market over the forecast period due to the preeminent role played by China in the development and conception of acupuncture. The traditional popularity of acupuncture in China has seen the region hold on to the top spot in the global acupuncture market, while countries around China, such as India, Korea, Australia, and Japan have also emerged as key markets for acupuncture services in recent years. The growing popularity of alternative medicine in these countries and the growing healthcare expenditure, thanks to the growing disposable income of consumers in the region, are likely to drive the acupuncture market in the region over the forecast period.

North America is another leading regional market for acupuncture products and services thanks to the growing influence of the New Age movement, which has led to increasing resistance to conventional Western medicine and increasing acceptance of other, less invasive, and supposedly more effective forms of alternative medicine. The increasing healthcare expenses in the U.S. are also likely to remain a key driver for the acupuncture market, though the lack of insurance coverage could hinder the market from going mainstream.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cardiac Tamponade Market Players Analysis By Segmentations, Regional Analysis, Future Development by 2032

 

Overview:

The global cardiac tamponade market size can score a CAGR of 5.80 % between 2023 and 2032 that can be considered as the forecast period.

Cardiac tamponade can be defined as the accumulation of fluid inside the sac circling the heart (pericardium), which increases pressure on the heart and makes it difficult for the heart to pump. The end result is curbing in the blood volume. This can cause shortness of breath, light-headedness, weakness, fatigue, cough, and others. This can trigger other diseases and their manifestation can lead to kidney failure, connective tissue diseases, chest trauma, aortic rupture, hypothyroidism, pericarditis,  tuberculosis etc. It can be life-threatening if not treated in time.

The cardiac tamponade market insight is gaining significant attention as patients are often registering symptoms that are direct results of the disease. In addition, the healthcare sector is witnessing a steep surge in investment that can trigger better research and development. People are now getting backed by reimbursements that is boosting the acknowledgment of the disease as more and more people are now going to physicians to treat the disease. These factors can smoothen up the track for the cardiac tamponade market growth.

Competitive Landscape:

Companies are lining up new products to get into the cardiac tamponade market for This is a strategic move that is for sure would cement their market footing. However, they employ other methods as well like merger, acquisition, and others. These companies have been profiled in detail in the market report by MRFR.

cardiac tamponade market players are Medtronic, Inc., Boston Scientific Corporation, Hitachi, Ltd., St. Jude Medical Inc., Siemens Healthcare Private Limited, Koninklijke Philips N.V., General Electric Company, Toshiba Medical Systems Corporation, and others.

Segmentation:

MRFR’s take on the global market for cardiac tamponade includes various segments to get a closer view of the core of the market. These segments are treatment, diagnosis, and end users. The segmentation has been supported by volume-wise and value-wise analyses.

By diagnosis, the market for cardiac tamponade can be segmented into electrocardiogram (EKG), x-ray, computed tomography (CT), coronary angiography, magnetic resonance imaging (MRI), and others.

By treatment, the market for cardiac tamponade includes surgery and drugs. The surgery segment incorporates pericardiocentesis, thoracotomy and others. The drugs segment covers blood volume expanders, antibiotics, and others.

 

By end users, the market for cardiac tamponade comprises academic & research, hospitals & clinics, and others. The hospitals & clinics segment may find the growth to be substantial in the coming years.

Regional Analysis:

The Americas can be considered the leader of the market as the revenue generated by the region is significantly higher than other regions. There are countries in the region who would trigger growth by their investment capacity, superior infrastructure, better technical integration, and others. North America would gain better heights than South due to the presence of countries like the US and Canada. The expenditure of these two countries for their healthcare budget is relatively higher, which can ensure that the market would proliferate in better ways.

Europe’s market would gain better traction with the presence of countries like the UK, France, Germany, and others. The region is banking on superior research and development facilities.

The APAC market is expecting superior growth due to the investment made by countries like India, China, and others. Japan’s market in such scenarios is quite well-developed. On the other hand, global players are finding the region a suitable investment option where they can increase their profit by tapping on the large population. Hence, their investment is flowing in, which can make substantial changes in the market. The Middle East & Africa market would find distraction in the poor economies of Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Corneal Transplant Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2032

 

Global Corneal Transplant Market   - Overview

Accrediting the kind of growth, the market is witnessing and the growth prospect the market is demonstrating, Market Research Future (MRFR), has recently published a brilliant study report. According to MRFR, the Global Corneal Transplant market size is expected to perceive exponential growth 11.20% CAGR during the forecasted period (2023 -2032).

The global Corneal Transplant Market insights is growing pervasively over last decade. Factors such as increasing prevalence injuries & diseases related to the eye/ sight that fuel the transplants cases are fuelling the market growth to an extent. Also the risk factors for the blindness & eye sight disorders are creating the demand for the better Corneal Transplants and treatment methods in turn, speed up the market growth.

Other factors propelling the market growth include the changing lifestyle owing to the growing urbanization & industrialization coupled with the growing economic conditions that enable access to the quality life & to the improved healthcare worldwide. Advancements in surgeries, fuel the market growth. In addition, factors such as increasing number of surgeries and rising demand for new techniques for the treatment provide major impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with Corneal Transplant and the differential awareness and availability between developing and the developed world are posing challenges to the market growth. Nevertheless, new products and services offered to the developing countries and emerging economies by the well-established market players in the developed countries are filling up this gap. This will resultantly foster the market growth.

Global Corneal Transplant Market   - Competitive Analysis

Global Corneal Transplant market players are

Florida Lions Eye Bank

CorNeat Vision

CorneaGen

San Diego Eye Bank

Alabama Eye Bank

Aurolab

Cornea Biosciences

KERAMED INC.

Price Vision Group

0 LinkoCare LifeSciences AB

Presbia PLC

AJL Ophthalmic SA

DIOPTER

Massachusetts Eye and Ear

The global Corneal Transplant market is a fragmented market with a large number of players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines have reduced the total market revenues and at the same time displaced standard drugs off the market.

Global Corneal Transplant Market      - Segments

For an easy grasp and enhanced understanding, the report - Global Corneal Transplant Market is segmented in to 4 Key dynamics;

 

By Surgery Types       : Comprises - Penetrating Keratoplasty, DSAEK (Descemet Stripping Automated Endothelial Keratoplasty), Endothelial Keratoplasty, Corneal Graft, and Corneal Limbal Stem Cell Transplant among others.

By Indications            : Bullous Keratopathy, Fungal Corneal Ulcer, Keratoconus, Corneal Stromal Dystrophies, and Keratitis among others.

By End Users               : Hospitals & Eye clinics among others.

By Regions                  :  North America, Europe, APAC and Rest of the World.

Global Corneal Transplant Market   - Regional Analysis

Globally, Europe is the largest market for the Corneal Transplant. Factors such as the availability of multiple treatment options, prevention strategy as well as rising influence of organ donation programs, coupled with the increased government emphasis on organ donation policies drive the regional growth of the market. Moreover, increasing prevalence of diabetes in the region are providing impetus to the market growth.

While North America region stands as the second-largest market for Corneal Transplant. This growth attributes to the increasing demand for corneal transplant surgery coupled with the growing prevalence of eye diseases, and vision impairment among people in the region drive the regional market growth. Moreover, growing Centers for Disease Control and Prevention, coupled with the age-related eye diseases such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma are leading causes of blindness and vision imparity especially in the United States; such factors foster the regional market growth.

On the other hand the developing regions markets particularly Asia Pacific will be the fastest growing market for Corneal Transplant. Risk factors for the eye diseases such as the ever-increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity provide impetus to the growth of the regional market. Attributing to the availability of qualitative eye care treatment and skilled medical professionals, India has become one of the international medical tourism destinations across the world. This, in turn fuels the growth of corneal transplant market in India resultantly, fostering the growth of the APAC market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Syringe and Needle Market Insights To Witness Notable Growth During the Forecast Period 2023-2032

 

Market Overview-

The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). The syringe and needle market is growing primarily on account of a large pool of patients who augment the demand for needle and syringe. High prevalence of blood-borne diseases leads to a surge in the application of syringes and needles which fuels the market growth. The global geriatric population is increasing and contributing significantly to the market growth. This demographic is at high risk for chronic diseases, and the natural aging process weakens the body leading to increased overall medical visits. Increased demand for hypodermic needles which prevent the risk of needle-stick injuries also aids the growth of the market. Implementation of vaccination programs for diseases such as hepatitis, polio, rubella, tetanus, etc., also induces demand for needles and syringes which help in market expansion. Increase in a number of injectable drugs approved by the FDA also propels the market for syringes and needles. However, the growth of the market might be hindered by the risk associated with re-use and sharing of needles and syringes. Reuse of needles exposes consumers to the risk of acquiring diseases such as HIV and hepatitis C which is a major setback and constrain to the market growth. Risk of needlestick injuries and availability of alternatives also hinders the growth of the market. The market growth might be threatened by the introduction of needleless alternatives to meet the demands of a minimally invasive medical procedures.

Competitive Landscape

Global Syringe and Needle Market Players include

·         B. Braun Medical Inc.,

·         Terumo Corporation,

·         Albert David Ltd,

·         Covidien Plc,

·         Smiths Medical, and

·         Connecticut Hypodermics Inc.

 

Segmentation

The global syringes and needle market insights has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

 

Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.

 

 

Industry Updates

An American pharmacy, Sunrise Pharmacy is reportedly accepting discarded needles found in public spaces for a reward of 5 cents per used needle. The move is an attempt to solve the issue of discarded drug paraphernalia. 

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Adenomyosis Treatment Market Players Analysis By Segmentations, Regional Analysis, Future Development by 2032

 

Market overview

Adenomyosis is defined as a medical condition in which the inner lining of the uterus (also known as the endometrium) breaks through the muscle wall of the uterus (the myometrium). The treatment of this medical problem is called adenomyosis treatment. A new report on the global adenomyosis treatment market, published by Market Research Future (MRFR), states that global adenomyosis treatment market size can visualize progress at 6.20% CAGR during the forecast period (2023-2032).

The biggest driver for the global adenomyosis treatment market growth is the global prevalence of adenomyosis. The increasing awareness about adenomyosis as well as its treatment is boosting the global adenomyosis treatment market insight by creating the demand, supply, and sales for new drugs and therapies, along with advanced medical technology-focused towards the adenomyosis. Hence, new opportunities are arising for market growth. During the forecast period, increased funding for research & development (R&D) to develop more advanced products (medical devices) is expected to reflect favorably on the market. However, the market in developing countries can face hurdles as many people are not aware of this medical problem.

Key Players

Global adenomyosis treatment market players are Bayer AG (Germany), Ferring B.V. (Switzerland), Johnson & Johnson Consumer Inc. (USA), Merck KGaA (Germany), Novartis (Switzerland), Pfizer Inc. (USA) and Speciality European Pharma (UK).

 

Market Segmentation

The global adenomyosis treatment market segmentation encompasses diagnosis, type, and treatment. MRFR’s take on the market marks various facets of the market in-depth.

The diagnosis-based segmentation of this market covers endometrial biopsy, magnetic resonance imaging (MRI), ultrasound, and others. The ultrasound segment has been sub-segmented into transabdominal ultrasound and endovaginal ultrasound which is also known as transvaginal ultrasound.

By type, the market includes adenomyoma, diffuse, focal, and others.

By treatment, the market covers anti-inflammatory drugs, hormone medications, and hysterectomy. The anti-inflammatory drugs segment has been sub-segmented into Advil, ibuprofen, Motrin ibuprofen (Motrin IB), and others. The hormone medications segment has been sub-segmented into aromatase inhibitors and Gonadotropin-releasing hormone (GnRH) agonists. The hysterectomy segment radical hysterectomy, supracervical hysterectomy (also known as a subtotal hysterectomy), and total hysterectomy.  

Regional Segmentation

A geographical outlining of the global adenomyosis treatment market covers the Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA).

The Americas is the biggest regional market as North America alone has the potential of becoming a powerful regional market. Due to the advanced medical facilities being available in the USA North America is a larger regional market segment compared to South America. North America is the largest regional market segment due to the rapid adoption of new drugs and therapies. Continuous innovation on the technological front and heavy use of technology in the medical sector boost market in this region. USA and Canada are generating the maximum revenue in this region.

Europe is the second-largest regional market as many important market players are based in Europe. Due to the reasons the same as in The Americas, Western Europe is a bigger market compared to Eastern Europe. The major market share comes from France, Germany, Spain, Italy, and the UK.

The Asia Pacific region is an important regional market due to improving medical sector and stable technological progress. In this report, this regional market has been segmented into Asia and the Pacific. In Asia, the key country-specific markets are China, India, Japan, and South Korea. An observation of the remaining countries in Asia and the Pacific region featured in this report calculates the additional market revenue from some other countries.

In the MEA region, the market has been slow due to limited availability of advanced medical facilities. Countries focused in the report include Egypt, Saudi Arabia, and the UAE.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Healthcare Electronic Data Interchange Market Insights To Witness Notable Growth During the Forecast Period 2023-2030

 

Market Synopsis

 

Market Research Future (MRFR), in its latest “Global Healthcare Electronic Data Interchange (EDI) Market Size” was valued USD 2674 Mn in 2017 and is projected to grow at 8.60% CAGR by 2030. In the healthcare sector, the enormous generate of data through documents, such as, patient records, health insurance reimbursements, and others are required to be processed and sorted for convenient extraction. The traditional use of paper is an inefficient and cumbersome method. Thus, the need for electronic data interchange (EDI) in healthcare industry is surging. The efficacy of Edi that allows the presentation of healthcare data in standardized format to institutions, healthcare professionals, and patients can prompt the expansion of the global electronic data interchange market.

The rise in the adoption of EDI for performance management and operational intelligence is another determinate for the market expansion. EDI healthcare transactions offers elimination of paper trails and digitized transactions curbs reduction of costly errors. Moreover, healthcare players are observed to manage significant savings on deploying EDI. Other drives, such as increase in government support for development of IT-based healthcare projects and rise in the demand for reduction in healthcare expenses can accelerate the EDI market growth. In addition, the growing awareness about benefits of using EDI software, adoption of EDI software by reputed pharmaceuticals, and exercising favourable funding policies offered by different healthcare companies are anticipated to spur the growth of the electronic data interchange market.

On the downside, the high installation price of EDI software, hesitancy to remove conventional methods, and data security can limit the market expansion.

Key Players

Global Healthcare Electronic Data Interchange (EDI) Market Players are Cognizant, Allscripts Healthcare Solutions Inc., Siemens Healthineers, The SSI Group, LLC, Experian Information Solutions, Inc., ZirMed Inc., GE Healthcare, McKesson Corporation, Optum, Inc., Schreiner Group, Passport Health Communications, Emdeon Inc., and HealthFusion are some reputed companies functioning in the global healthcare electronic data interchange (EDI) software market.

Segmental Outline

The global market of healthcare electronic data interchange (EDI) market was studied by component, transaction, delivery mode, and end user.

Software and services are electronic data interchange market’s component-based segments. Web and cloud-based EDI, direct (Point-to-Point) EDI, EDI value added network (VAN), and mobile EDI are delivery-mode based segments of the EDI market. The market’s transaction-based segments are payment & remittance advance, claims & encounters, claim attachments, eligibility inquiry and response, enrolments, claim status and response, and referral certification and authorization. By end user, the market segments are pharmaceutical & medical device industries, healthcare providers, and healthcare payers, others. The healthcare payers segment can hold the grand share of the overall market as the rate of adoption of EDI by clinicians and physicians for financial management is high. The pharmaceutical and medical device segment can strike a decent CAGR through the study period.

Regional Summary

Americas healthcare electronic data interchange market to be in the forefront. The high pace growth of the healthcare electronic data interchange (EDI) market in Americas can be attributed to surge in healthcare expenditure, increased participation of marketers, and disruptive technologies in EDI software.

Europe EDI market expansion can be attributed to hefty funds offered by governments and the presence of favourable policy implementation.

Asia Pacific healthcare electronic data interchange software market insights can surge at a high growth rate due to increased investment in information technology. As per the report offered by India Brand Equity Foundation (IBEF), India’s heavy investment in the development of information technology sector can bolster the expansion of the regional EDI market through the evaluation period.

In MEA, the market of healthcare electronic data interchange software can emerge in coming years.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Healthcare Data Storage Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market Analysis

 

The global healthcare data storage market size is projected to touch a 15.30% CAGR between 2023-2032, as per the recent Market Research Future (MRFR) report. Healthcare data storage, simply put, are software solutions that are utilized by diagnostic centers, clinics, and hospitals for storing patient data that can be used in the future. 

 

Numerous factors are adding to the global healthcare data storage market growth. These factors, according to the recent Market Research Future report, comprise increasing use of EMR and EHR, increasing support from the government, increasing collaborations between IT and healthcare companies, increasing demand for software for safe clinical data storage, and demand for storage solution. 

 

On the contrary, high training costs and high implementation cost of EHR and EMR, rising cyber-attacks, healthcare fraud, and data security concerns are factors that may deter the healthcare data storage market growth over the forecast period. 

 

Key Players

 

Global healthcare data storage market players profiled in the report include Carestream Corporation (US), Nuance Communications, Inc (US), Western Digital (US), Hitachi (Japan), Pure Storage (US), Hewlett Packard Enterprise (HPE)(US), NetApp (US), IBM Corporation (US), Dell Inc. (US), and DataCore Software (US). Key players have incorporated several strategies to create a niche in the market, such as strategic alliances, mergers and acquisitions, collaborations, product developments, and others. 

 

Market Segmentation 

 

The Market Research Future report provides an all-inclusive segmental analysis of the global healthcare data storage market based on end user, storage system, type, architecture, application, and solution. 

 

By solution, the healthcare data storage market is segmented into hybrid data storage, cloud, and on-premise. Of these, on-premise will lead the market during the forecast period. 

 

By application, the healthcare data storage market insights is segmented into operational analysis, financial analysis, and clinical analysis. Clinical analysis is again segmented into precision health, population health management, reporting and compliance, quality control, and clinical decision support. Financial analysis is again segmented into risk adjustment and assessment, claim processing, revenue cycle management, and others. Of these, clinical analysis will dominate the market during the forecast period for the increase in the number of diagnostic centers, clinics, and hospitals. 

 

By architecture, the healthcare data storage market is segmented into block storage, object storage, and file storage. Of these, the object storage segment will have the largest share in the market during the forecast period. 

 

By type, the healthcare data storage market is segmented into magnetic storage and flash & solid-state storage. Magnetic storage is again segmented into magnetic tapes and magnetic disks. Of these, flash and solid-state storage will dominate the market during the forecast period. 

 

By storage system, the healthcare data storage market is segmented into direct-attached storage, network-attached storage, and storage area network. Of these, the storage area network will lead the market during the forecast period. 

 

By end user, the healthcare data storage market is segmented into contract manufacturing organizations, clinical/contract research organizations, pharmaceuticals and biotechnology, hospitals and clinics, and others. Among these hospitals and clinics will dominate the market during the forecast period. 

 

Regional Analysis 

 

By region, the global healthcare data storage market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market during the forecast period for the use of innovative solutions by clinics and hospitals for maintaining patient data and the availability of the most up to date healthcare information technology solutions. 

 

The global healthcare data storage market in Europe will hold the second-largest share during the forecast period owing to the presence of several healthcare companies offering diagnostic and treatment products, thereby increasing the demand for IT solutions for healthcare data storage. Besides, the presence of a huge patient population suffering from arthritis, diabetes, and cancer is also boosting the market growth. 

 

The global healthcare data storage market in the APAC region is predicted to grow at the fastest pace over the forecast period for rapid technological developments and the presence of several developing countries, especially China, India, and Japan. 

 

The global healthcare data storage market in the MEA will have steady growth during the forecast period for growing technological advances and developing healthcare infrastructure. 

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Growing Adoption of Non-Invasive Tattoo Removal Techniques: Market Implications

Tattoo Removal Market: Overview and Trends The tattoo removal market is a dynamic and growing sector within the global aesthetics industry...